Semaglutide and Heart Health: What the SELECT Trial Means for Weight Management

Introduction

When people think about weight loss treatment, the focus is often on body weight, appearance, or clothing size. However, obesity is also closely connected with long-term health risks, including cardiovascular disease, high blood pressure, abnormal cholesterol, and metabolic changes.

This is why modern weight management research is increasingly looking beyond the number on the scale.

The SELECT trial, published in the New England Journal of Medicine, investigated whether semaglutide could reduce major cardiovascular events in adults with overweight or obesity who already had cardiovascular disease but did not have diabetes.

The findings showed that semaglutide was associated with a lower risk of major cardiovascular events compared with placebo in this specific patient population. fileciteturn3file0

However, these results do not mean that everyone with excess weight needs medication or that semaglutide replaces standard heart disease prevention. Treatment decisions should always consider a person’s overall health, medical history, and individual risk factors.

What Is Semaglutide?

Semaglutide is a medication that belongs to a class called GLP-1 receptor agonists.

GLP-1 is a naturally occurring hormone involved in:

• Appetite regulation

• Blood sugar control

• Digestion

• Energy balance

By activating GLP-1 pathways, semaglutide can help support reduced appetite and weight management in suitable patients.

GLP-1 receptor agonists have already been studied extensively in people with diabetes and have shown cardiovascular benefits in certain high-risk populations. The SELECT trial explored whether these benefits could also apply to people with overweight or obesity without diabetes. fileciteturn3file0

Why Cardiovascular Health Matters in Obesity

Obesity is not only about body size. Excess body fat, especially around internal organs, can affect many systems throughout the body.

Higher body weight is associated with increased risk of:

• Heart disease

• Stroke

• High blood pressure

• Type 2 diabetes

• Abnormal cholesterol

• Chronic inflammation

The SELECT trial researchers noted that overweight and obesity are independently associated with cardiovascular risk, even after considering traditional risk factors such as blood pressure, cholesterol, and blood sugar. fileciteturn3file0

This is why weight management is increasingly viewed as part of broader preventive healthcare.

What Was the SELECT Trial?

The SELECT trial was a large, international, randomised, double-blind, placebo-controlled clinical trial.

The study included:

• 17,604 adults

• Age 45 years or older

• BMI of 27 or higher

• Existing cardiovascular disease

• No history of diabetes

Participants were randomly assigned to receive:

• Weekly semaglutide 2.4 mg injection

• Placebo

The average follow-up period was approximately 39.8 months.

The main question was whether semaglutide could reduce major cardiovascular events, including:

• Cardiovascular death

• Non-fatal heart attack

• Non-fatal stroke

fileciteturn3file0

What Did the SELECT Trial Find?

The primary cardiovascular outcome occurred in:

• 6.5% of participants receiving semaglutide

• 8.0% of participants receiving placebo

The trial reported a hazard ratio of 0.80, meaning semaglutide was associated with a 20% relative reduction in the risk of the primary cardiovascular outcome compared with placebo in this study population. fileciteturn3file0

These results were specific to adults with overweight or obesity, established cardiovascular disease, and without diabetes.

They should not automatically be applied to every person considering weight management treatment.

Did Semaglutide Also Affect Weight?

Yes. Weight reduction was one of the important findings of the SELECT trial.

Over 104 weeks:

• Average body weight reduction with semaglutide was approximately 9.4%

• Average body weight change with placebo was approximately 0.9%

Waist circumference also decreased more with semaglutide compared with placebo. fileciteturn3file0

Reducing excess body weight may improve several health markers, including blood pressure, blood sugar regulation, cholesterol, and inflammation.

However, individual results vary significantly depending on lifestyle, genetics, starting weight, treatment adherence, and medical factors.

How Could Weight Management Affect Heart Health?

Researchers believe cardiovascular improvements may involve several pathways.

Possible contributing factors include:

Reduced Excess Body Fat

Excess body fat can contribute to inflammation and metabolic changes. Reducing body weight may improve some of these processes.

Improved Blood Pressure

The SELECT trial reported improvements in blood pressure measurements with semaglutide compared with placebo.

Improved Metabolic Markers

The study also observed improvements in several cardiometabolic markers, including:

• HbA1c levels

• Lipid measurements

• C-reactive protein levels

fileciteturn3file0

Appetite and Energy Balance

GLP-1 receptor activation may influence appetite regulation, making it easier for some patients to maintain reduced calorie intake as part of a structured weight-management plan.

Who May Benefit From a Cardiovascular Risk Assessment?

Not everyone with a higher BMI requires medication. However, a cardiovascular and metabolic assessment may be useful for people with:

• BMI above recommended ranges

• Previous heart disease

• High blood pressure

• Prediabetes

• High cholesterol

• Family history of cardiovascular disease

• Fatty liver concerns

• Difficulty managing weight despite lifestyle changes

A doctor can help determine whether the focus should be lifestyle support, medical weight management, cardiovascular prevention, or a combination approach.

When Should You Consider Medical Weight Management?

You may consider a medical consultation if:

• Weight is affecting your health

• You have repeated unsuccessful weight-loss attempts

• You have metabolic risk factors

• You have difficulty controlling appetite

• You have obesity-related conditions

• You want to understand your treatment options

Weight management is not only about losing weight. It is about improving overall health and reducing future risks where possible.

What a Doctor May Assess

A doctor-led approach may include:

• Medical consultation

• Weight and BMI assessment

• Waist circumference measurement

• Blood pressure evaluation

• Health history review

• Cardiovascular risk assessment

• Blood tests if needed

• HbA1c and glucose review

• Cholesterol testing

• Review of current medication

• Treatment options

• Follow-up guidance

This helps ensure treatment decisions are based on health needs rather than weight alone.

Benefits and Key Points to Understand

The SELECT trial provides important evidence that weight management may have benefits beyond reducing body weight for certain high-risk patients.

Key points include:

• Obesity is linked with cardiovascular risk

• Weight management can involve more than appearance

• Semaglutide reduced major cardiovascular events in the SELECT trial population

• Weight reduction was accompanied by improvements in some health markers

• Results may not apply to every patient

• Medical assessment is important before starting treatment

The goal of weight management should be improved health, not simply achieving a specific number on the scale.

Safety, Side Effects, and Important Considerations

Like all medications, semaglutide may cause side effects.

In the SELECT trial, common concerns included gastrointestinal symptoms. Gastrointestinal adverse effects were more common with semaglutide, and some participants discontinued treatment because of side effects. fileciteturn3file0

Possible side effects may include:

• Nausea

• Vomiting

• Diarrhoea

• Constipation

• Digestive discomfort

Some patients may not be suitable for semaglutide because of medical history, medication interactions, pregnancy status, or other health considerations.

A doctor should review suitability before treatment.

Why Doctor-Led Care Matters

Cardiovascular health and weight management are complex. Two people with the same BMI may have very different risks depending on:

• Blood pressure

• Cholesterol

• Blood sugar

• Family history

• Body composition

• Existing medical conditions

• Lifestyle factors

Doctor-led care helps ensure treatment decisions are personalised, medically appropriate, and regularly reviewed.

Medication is only one part of a complete health plan.

Book a Weight Management Consultation in Bangkok

MedConsult Clinic provides doctor-led weight management consultations in Bangkok for patients who want to better understand their metabolic health and treatment options.

A consultation may include discussion of weight history, cardiovascular risk factors, blood tests, lifestyle factors, and whether medical weight management may be suitable.

Book a consultation at MedConsult Clinic to discuss your health goals and receive personalised medical guidance.